2,045
Views
8
CrossRef citations to date
0
Altmetric
Reviews

A systematic review of ethical issues in vaccine studies involving pregnant women

, , , , &
Pages 1952-1959 | Received 09 Nov 2015, Accepted 30 Apr 2016, Published online: 15 Jul 2016

References

  • WHO UNICEF World Bank. State of the world's vaccines and immunization. 3rd ed. 2009, Geneva: World Health Organization
  • Makris MC, Polyzos KA, Mavros MN, Athanasiou S, Rafailidis PI, Falagas ME. Safety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: a systematic review. Drug Saf 2012; 35(1):1-14; PMID:22149417; http://dx.doi.org/10.2165/11595670-000000000-00000
  • Omer SB, Goodman D, Steinhoff MC, Rochat R, Klugman KP, Stoll BJ, Ramakrishnan U. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med 2011; 8(5):e1000441; PMID:21655318; http://dx.doi.org/10.1371/journal.pmed.1000441
  • Macroepidemiology of Influenza Vaccination Study, G. The macro-epidemiology of influenza vaccination in 56 countries, 1997–2003. Vaccine 2005; 23(44):5133-43; PMID:16039762; http://dx.doi.org/10.1016/j.vaccine.2005.06.010
  • van Essen GA, Palache AM, Forleo E, Fedson DS. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 2003; 21(16):1780-5; PMID:12686094; http://dx.doi.org/10.1016/S0264-410X(03)00072-0
  • World Health Organization. Vaccines against influenza WHO position paper – November 2012. Weekly Epidemiological Record 2012; 47(87):461-76
  • Keller-Stanislawski B, Englund JA, Kang G, Mangtani P, Neuzil K, Nohynek H, Pless R, Lambach P, Zuber P. Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines. Vaccine 2014; 32(52):7057-64; PMID:25285883; http://dx.doi.org/10.1016/j.vaccine.2014.09.052
  • Lambach P, Hombach J, Ortiz JR. A global perspective of maternal immunization. Vaccine 2015; 33(47):6376-9; PMID:26319068; http://dx.doi.org/10.1016/j.vaccine.2015.08.036
  • US. Code of Federal Regulations 45 CFR 46. Protection of human subjects. 2009
  • Foulkes MA, Grady C, Spong CY, Bates A, Clayton JA. Clinical research enrolling pregnant women: a workshop summary. J Womens Health (Larchmt) 2011; 20(10):1429-32; PMID:21819233; http://dx.doi.org/10.1089/jwh.2011.3118
  • Bhan A. Influenza Vaccination in Pregnancy: Overview of ethical issues. June 2011, Maternal Influenza Immunization Convening
  • Lambach P, Alvarez AM, Hirve S, Ortiz JR, Hombach J, Verweij M, Hendriks J, Palkonyay L, Pfleiderer M. Considerations of strategies to provide influenza vaccine year round. Vaccine 2015; 33(47):6493-8; PMID:26319745; http://dx.doi.org/10.1016/j.vaccine.2015.08.037
  • Meeting of the Strategic Advisory Group of Experts on immunization, April 2015: conclusions and recommendations. Wkly Epidemiol Rec 2015; 90(22):261-78; PMID:26027016
  • Hashim R, Khatib AM, Enwere G, Park JK, Reyburn R, Ali M, Chang NY, Kim DR, Ley B, Thriemer K, et al. Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy. PLoS Negl Trop Dis 2012; 6(7):e1743; PMID:22848772; http://dx.doi.org/10.1371/journal.pntd.0001743
  • Fischer GW, Ottolini MG, Mond JJ. Prospects for vaccines during pregnancy and in the new born period. Clin Perinatol 1997; 24(1):231-49; PMID:9099512
  • Auffret M, Béné J, Gautier S, Moreau-Crépeaux S, Caron J. Pharmacovigilance monitoring of a cohort of pregnant women vaccinated against influenza A(H1N1) variant virus in the Nord-Pas de Calais region of northern France. Eur J Obstet Gynecol Reprod Biol 2013; 170(1): p. 114-8; PMID:23810001; http://dx.doi.org/10.1016/j.ejogrb.2013.05.025
  • Bednarczyk RA, Adjaye-Gbewonyo D, Omer SB. Safety of influenza immunization during pregnancy for the fetus and the neonate. Am J Obstet Gynecol 2012; 207(3 Suppl):S38-46; PMID:22920058; http://dx.doi.org/10.1016/j.ajog.2012.07.002
  • Cantu J, Biggio J, Jauk V, Wetta L, Andrews W, Tita A. Selective uptake of influenza vaccine and pregnancy outcomes. J Matern Fetal Neonatal Med 2013; 26(12):1207-11; PMID:23406444; http://dx.doi.org/10.3109/14767058.2013.775419
  • Christian LM, Iams JD, Porter K, Glaser R. Inflammatory responses to trivalent influenza virus vaccine among pregnant women. Vaccine 2011; 29(48):8982-7; PMID:21945263; http://dx.doi.org/10.1016/j.vaccine.2011.09.039
  • Huang G, Liu H, Cao Q, Liu B, Pan H, Fu C. Safety of post-exposure rabies prophylaxis during pregnancy: a follow-up study from Guangzhou, China. Hum Vaccin Immunother 2013; 9(1):177-83; PMID:23442589; http://dx.doi.org/10.4161/hv.22377
  • Kharbanda EO, Vazquez-Benitez G, Lipkind H, Naleway A, Lee G, Nordin JD. Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events. Obstet Gynecol 2013; 122(3):659-67; PMID:23921876; http://dx.doi.org/10.1097/AOG.0b013e3182a1118a
  • Lin SY, Wu ET, Lin CH, Shyu MK, Lee CN. The Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccination: A Study of Maternal-Cord Blood Pairs in Taiwan. PLoS One 2013; 8(6):e62983; PMID:23762229
  • Moro PL, Tepper NK, Grohskopf LA, Vellozzi C, Broder K. Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy. Expert Rev Vaccines 2012; 11(8):911-21; PMID:23002972 http://dx.doi.org/10.1586/erv.12.72
  • Munoz FM, Greisinger AJ, Wehmanen OA, Mouzoon ME, Hoyle JC, Smith FA, Glezen WP. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2005; 192(4):1098-106; PMID:15846187; http://dx.doi.org/10.1016/j.ajog.2004.12.019
  • Naleway AL, Irving SA, Henninger ML, Li DK, Shifflett P, Ball S, Williams JL, Cragan J, Gee J, Thompson MG, et al. Safety of influenza vaccination during pregnancy: A review of subsequent maternal obstetric events and findings from two recent cohort studies. Vaccine 2014; 32(26):3122-7; PMID:24742490; http://dx.doi.org/10.1016/j.vaccine.2014.04.021
  • Sheffield JS, Greer LG, Rogers VL, Roberts SW, Lytle H, McIntire DD, Wendel GD, Jr. Effect of influenza vaccination in the first trimester of pregnancy. Obstet Gynecol 2012; 120(3):532-7; PMID:22914461; http://dx.doi.org/10.1097/AOG.0b013e318263a278
  • Sheffield JS, Hickman A, Tang J, Moss K, Kourosh A, Crawford NM, Wendel GD, Jr. Efficacy of an accelerated hepatitis B vaccination program during pregnancy. Obstet Gynecol 2011; 117(5):1130-5; PMID:21508752; http://dx.doi.org/10.1097/AOG.0b013e3182148efe
  • Adedinsewo DA, Noory L, Bednarczyk RA, Steinhoff MC, Davis R, Ogbuanu C, Omer SB. Impact of maternal characteristics on the effect of maternal influenza vaccination on fetal outcomes. Vaccine 2013; 31(49):5827-33; PMID:24120677; http://dx.doi.org/; http://dx.doi.org/10.1016/j.vaccine.2013.09.071
  • Sheffield JS, Munoz FM, Beigi RH, Rasmussen SA, Edwards KM, Read JS, Heine RP, Ault KA, Swamy GK, Jevaji I, et al. Research on vaccines during pregnancy: reference values for vital signs and laboratory assessments. Vaccine 2013; 31(40):4264-73; PMID:23906887; http://dx.doi.org/10.1016/j.vaccine.2013.07.031
  • Lehmann D, Pomat WS, Riley ID, Alpers MP. Studies of maternal immunisation with pneumococcal polysaccharide vaccine in Papua New Guinea. Vaccine 2003; 21(24):3446-50; PMID:12850357; http://dx.doi.org/10.1016/S0264-410X(03)00348-7
  • Ortiz JR, Neuzil KM, Ahonkhai VI, Gellin BG, Salisbury DM, Read JS, Adegbola RA, Abramson JS. Translating vaccine policy into action: a report from the Bill & Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings. Vaccine 2012; 30(50):7134-40; PMID:23026690; http://dx.doi.org/10.1016/j.vaccine.2012.09.034
  • Fulton TR, Narayanan D, Bonhoeffer J, Ortiz JR, Lambach P, Omer SB. A systematic review of adverse events following immunization during pregnancy and the newborn period. Vaccine 2015; 33(47):6453-65; PMID:26413879; http://dx.doi.org/10.1016/j.vaccine.2015.08.043
  • Levac D, Colquhoun H, O'Brien KK. Scoping studies: advancing the methodology. Implement Sci 2010; 5:69; PMID:20854677; http://dx.doi.org/10.1186/1748-5908-5-69
  • Bonhoeffer J, Zumbrunn B, Heininger U. Reporting of vaccine safety data in publications: systematic review. Pharmacoepidemiol Drug Saf 2005; 14(2):101-6; PMID:15386705; http://dx.doi.org/10.1002/pds.979
  • Strech D, Mertz M, Knüppel H, Neitzke G, Schmidhuber M. The full spectrum of ethical issues in dementia care: systematic qualitative review. Br J Psychiatry 2013; 202:400-6; PMID:23732935; http://dx.doi.org/10.1192/bjp.bp.112.116335
  • Baker CJ, Rench MA, Edwards MS, Carpenter RJ, Hays BM, Kasper DL. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N Engl J Med 1988; 319(18):1180-5; PMID:3050524; http://dx.doi.org/10.1056/NEJM198811033191802
  • Cavalcanti DP, Salomão MA, Lopez-Camelo J, Pessoto MA. Early exposure to yellow fever vaccine during pregnancy. Trop Med Int Health 2007; 12(7):833-7; PMID:17596249; http://dx.doi.org/10.1111/j.1365-3156.2007.01851.x
  • Chambers CD, Johnson D, Xu R, Luo Y, Louik C, Mitchell AA, Schatz M, Jones KL. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants. Vaccine 2013; 31(44):5026-32; PMID:24016809; http://dx.doi.org/10.1016/j.vaccine.2013.08.097
  • Conlin AM, Bukowinski AT, Sevick CJ, DeScisciolo C, Crum-Cianflone NF. Safety of the pandemic H1N1 influenza vaccine among pregnant US military women and their newborns. Obstet Gynecol 2013; 121(3):511-8; PMID:23635612; http://dx.doi.org/10.1097/AOG.0b013e318280d64e
  • Jackson LA, Patel SM, Swamy GK, Frey SE, Creech CB, Munoz FM, Artal R, Keitel WA, Noah DL, Petrie CR, et al. Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. J Infect Dis 2011; 204(6):854-63; PMID:21849282; http://dx.doi.org/10.1093/infdis/jir440
  • Lin TH, Lin SY, Lin CH, Lin RI, Lin HC, Chiu TH, Cheng PJ, Lee CN. AdimFlu-S((R)) influenza A (H1N1) vaccine during pregnancy: the Taiwanese Pharmacovigilance Survey. Vaccine 2012; 30(16):2671-5; PMID:22342546; http://dx.doi.org/10.1016/j.vaccine.2012.02.008
  • Munoz FM, Bond NH, Maccato M, Pinell P, Hammill HA, Swamy GK, Walter EB, Jackson LA, Englund JA, Edwards MS, et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA 2014; 311(17):1760-9; PMID:24794369; http://dx.doi.org/10.1001/jama.2014.3633
  • Munoz FM, Englund JA, Cheesman CC, Maccato ML, Pinell PM, Nahm MH, Mason EO, Kozinetz CA, Thompson RA, Glezen WP. Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation. Vaccine 2001; 20(5-6):826-37; PMID:11738746; http://dx.doi.org/10.1016/S0264-410X(01)00397-8
  • Munoz FM, Piedra PA, Glezen WP. Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. Vaccine 2003; 21(24):3465-7; PMID:12850361; http://dx.doi.org/10.1016/S0264-410X(03)00352-9
  • Nordin JD, Kharbanda EO, Benitez GV, Nichol K, Lipkind H, Naleway A, Lee GM, Hambidge S, Shi W, Olsen A. Maternal safety of trivalent inactivated influenza vaccine in pregnant women. Obstet Gynecol 2013; 121(3):519-25; PMID:23635613; http://dx.doi.org/10.1097/AOG.0b013e3182831b83
  • Nordin JD, Kharbanda EO, Vazquez Benitez G, Lipkind H, Vellozzi C, Destefano F. Maternal influenza vaccine and risks for preterm or small for gestational age birth. J Pediatr 2014; 164(5):1051-1057 e2; PMID:24582484; http://dx.doi.org/10.1016/j.jpeds.2014.01.037
  • Oppermann, M, Fritzsche J, Weber-Schoendorfer C, Keller-Stanislawski B, Allignol A, Meister R, Schaefer C. A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine 2012; 30(30):4445-52; PMID:22564554; http://dx.doi.org/10.1016/j.vaccine.2012.04.081
  • Pasternak B, Svanström H, Mølgaard-Nielsen D, Krause TG, Emborg HD, Melbye M, Hviid A. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy. JAMA 2012; 308(2):165-74; PMID:22782418; http://dx.doi.org/10.1001/jama.2012.6131
  • Pitisuttithum P, Rerks-Ngarm S, Bussaratid V, Dhitavat J, Maekanantawat W, Pungpak S, Suntharasamai P, Vanijanonta S, Nitayapan S, Kaewkungwal J, et al. Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand. PLoS One 2011; 6(12):e27837; PMID:22205930; http://dx.doi.org/10.1371/journal.pone.0027837
  • Quiambao BP, Nohynek HM, Käyhty H, Ollgren JP, Gozum LS, Gepanayao CP, Soriano VC, Makela PH. Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies. Vaccine 2007; 25(22):4470-7; PMID:17442467; http://dx.doi.org/10.1016/j.vaccine.2007.03.021
  • Sato HK, Sanajotta AT, Moraes JC, Andrade JQ, Duarte G, Cervi MC, Curti SP, Pannuti CS, Milanez H, Pessoto M, et al. Rubella vaccination of unknowingly pregnant women: the Sao Paulo experience, 2001. J Infect Dis 2011; 204 Suppl 2:S737-44; PMID:21954275; http://dx.doi.org/10.1093/infdis/jir419
  • Shakib JH, Korgenski K, Sheng X, Varner MW, Pavia AT, Byington CL. Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes. J Pediatr 2013; 163(5):1422-6 e1-4; PMID:23896191; http://dx.doi.org/10.1016/j.jpeds.2013.06.021
  • Suzano CE, Amaral E, Sato HK, Papaiordanou PM. The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil. Vaccine 2006; 24(9):1421-6; PMID:16236402; http://dx.doi.org/10.1016/j.vaccine.2005.09.033
  • Talbot EA, Brown KH, Kirkland KB, Baughman AL, Halperin SA, Broder KR. The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak. Vaccine 2010; 28(50):8001-7; PMID:20875487; http://dx.doi.org/10.1016/j.vaccine.2010.09.034
  • Tavares F, Cheuvart B, Heineman T, Arellano F, Dubin G. Meta-analysis of pregnancy outcomes in pooled randomized trials on a prophylactic adjuvanted glycoprotein D subunit herpes simplex virus vaccine. Vaccine 2013; 31(13):1759-64; PMID:23313657; http://dx.doi.org/10.1016/j.vaccine.2013.01.002
  • Zaman K, Roy E, Arifeen SE, Rahman M, Raqib R, Wilson E, Omer SB, Shahid NS, Breiman RF, Steinhoff MC. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008; 359(15):1555-64; PMID:18799552; http://dx.doi.org/10.1056/NEJMoa0708630
  • De Vries L, et al. Adjuvanted A/H1N1 (2009) influenza vaccination during pregnancy: Description of a prospective cohort and spontaneously reported pregnancy-related adverse reactions in the Netherlands. Birth Defects Research Part A - Clinical and Molecular Teratology 2014 ((De Vries L., [email protected]; van Hunsel F; Cuppers-Maarschalkerweerd B; van Puijenbroek E.) Netherlands Pharmacovigilance Centre Lareb's-Hertogenbosch the Netherlands)
  • Heikkinen T, Young J, van Beek E, Franke H, Verstraeten T, Weil JG, Della Cioppa G. Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am J Obstet Gynecol 2012; 207(3):177 e1-8; PMID:22939717; http://dx.doi.org/10.1016/j.ajog.2012.07.007
  • Horiya M, Hisano M, Iwasaki Y, Hanaoka M, Watanabe N, Ito Y, Kojima J, Sago H, Murashima A, Kato T, Yamaguchi K. Efficacy of double vaccination with the 2009 pandemic influenza A (H1N1) vaccine during pregnancy. Obstet Gynecol 2011; 118(4):887-94; PMID:21934453; http://dx.doi.org/10.1097/AOG.0b013e31822e5c02
  • Ludvigsson JF, Zugna D, Cnattingius S, Richiardi L, Ekbom A, Örtqvist Å, Persson I, Stephansson O. Influenza H1N1 vaccination and adverse pregnancy outcome. Eur J Epidemiol 2013; 28(7):579-88; PMID:23715672; http://dx.doi.org/10.1007/s10654-013-9813-z
  • Mackenzie IS, MacDonald TM, Shakir S, Dryburgh M, Mantay BJ, McDonnell P, Layton D. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. Br J Clin Pharmacol 2012; 73(5):801-11; PMID:22082196; http://dx.doi.org/10.1111/j.1365-2125.2011.04142.x
  • Santosham M, Englund JA, McInnes P, Croll J, Thompson CM, Croll L, Glezen WP, Siber GR. Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants. Pediatr Infect Dis J 2001; 20(10):931-40; PMID:11642626; http://dx.doi.org/10.1097/00006454-200110000-00005
  • Tavares F, Nazareth I, Monegal JS, Kolte I, Verstraeten T, Bauchau V. Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study. Vaccine 2011; 29(37):6358-65; PMID:21596080; http://dx.doi.org/10.1016/j.vaccine.2011.04.114
  • Wright P, Lambert JS, Gorse GJ, Hsieh RH, McElrath MJ, Weinhold K, Wara DW, Anderson EL, Keefer MC, Jackson S, et al. Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women. J Infect Dis 1999; 180(4):1080-8; PMID:10479134; http://dx.doi.org/10.1086/314985
  • Dana A, Buchanan KM, Goss MA, Seminack MM, Shields KE, Korn S, Cunningham ML, Haupt RM. Pregnancy outcomes from the pregnancy registry of a human papillomavirus type 6/111487;161487;18 vaccine. Obstet Gynecol 2009; 114(6):1170-8; PMID:19935016; http://dx.doi.org/10.1097/AOG.0b013e3181c2a122
  • Moro PL, Broder K, Zheteyeva Y, Revzina N, Tepper N, Kissin D, Barash F, Arana J, Brantley MD, Ding H, et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol 2011; 205(5):473 e1-9; PMID:21861964; http://dx.doi.org/10.1016/j.ajog.2011.06.047
  • Moro PL, Broder K, Zheteyeva Y, Walton K, Rohan P, Sutherland A, Guh A, Haber P, Destefano F, Vellozzi C, et al. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009. Am J Obstet Gynecol 2011; 204(2):146 e1-7; PMID:20965490; http://dx.doi.org/10.1016/j.ajog.2010.08.050
  • Moro PL, Museru OI, Broder K, Cragan J, Zheteyeva Y, Tepper N, Revzina N, Lewis P, Arana J, Barash F, et al. Safety of influenza A (H1N1) 2009 live attenuated monovalent vaccine in pregnant women. Obstet Gynecol 2013; 122(6):1271-8; PMID:24201689; http://dx.doi.org/10.1097/AOG.0000000000000010
  • Moro PL, Museru OI, Niu M, Lewis P, Broder K. Reports to the Vaccine Adverse Event Reporting System after hepatitis A and hepatitis AB vaccines in pregnant women. Am J Obstet Gynecol 2014; 210(6):561 e1-6; PMID:24378675; http://dx.doi.org/10.1016/j.ajog.2013.12.036
  • Zheteyeva Y, Moro PL, Yue X, Broder K. Safety of meningococcal polysaccharide-protein conjugate vaccine in pregnancy: a review of the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol 2013; 208(6):478 e1-6; PMID:23453881; http://dx.doi.org/10.1016/j.ajog.2013.02.027
  • Zheteyeva YA, Moro PL, Tepper NK, Rasmussen SA, Barash FE, Revzina NV, Kissin D, Lewis PW, Yue X, Haber P, et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol 2012; 207(1):59 e1-7; PMID:22727350; http://dx.doi.org/10.1016/j.ajog.2012.05.006
  • Toback SL, Beigi R, Tennis P, Sifakis F, Calingaert B, Ambrose CS. Maternal outcomes among pregnant women receiving live attenuated influenza vaccine. Influenza Other Respir Viruses 2012; 6(1):44-51; PMID:21672166; http://dx.doi.org/10.1111/j.1750-2659.2011.00266.x
  • Orenstein LA, Orenstein EW, Teguete I, Kodio M, Tapia M, Sow SO, Levine MM. Background Rates of Adverse Pregnancy Outcomes for Assessing the Safety of Maternal Vaccine Trials in Sub-Saharan Africa. PLoS One 2012; 7(10):e46638; PMID:23056380; http://dx.doi.org/10.1371/journal.pone.0046638
  • Launay O, Krivine A, Charlier C, Truster V, Tsatsaris V, Lepercq J, Ville Y, Avenell C, Andrieu T, Rozenberg F, et al. Low rate of pandemic A/H1N1 2009 influenza infection and lack of severe complication of vaccination in pregnant women: a prospective cohort study. PLoS One 2012; 7(12):e52303; PMID:23300637; http://dx.doi.org/10.1371/journal.pone.0052303
  • Abzug MJ, Nachman SA, Muresan P, Handelsman E, Watts DH, Fenton T, Heckman B, Petzold E, Weinberg A, Levin MJ. Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women. Clin Infect Dis 2013; 56(10):1488-97; PMID:23378284; http://dx.doi.org/10.1093/cid/cit057
  • Kallen B, Olausson PO. Vaccination against H1N1 influenza with Pandemrix((R)) during pregnancy and delivery outcome: a Swedish register study. BJOG 2012; 119(13):1583-90; PMID:22901103; http://dx.doi.org/10.1111/j.1471-0528.2012.03470.x
  • Ergenoglu AM, Yeniel AO, Yildirim N, Kazandi M, Akercan F, Sağol S. Rubella vaccination during the preconception period or in pregnancy and perinatal and fetal outcomes. Turk J Pediatr 2012; 54(3):230-3; PMID:23094531
  • Chavant F, Ingrand I, Jonville-Bera AP, Plazanet C, Gras-Champel V, Lagarce L, Zenut M, Disson-Dautriche A, Logerot S, Auffret M, et al. The PREGVAXGRIP study: a cohort study to assess foetal and neonatal consequences of in utero exposure to vaccination against A(H1N1)v2009 influenza. Drug Saf 2013; 36(6):455-65; PMID:23516007; http://dx.doi.org/10.1007/s40264-013-0030-1
  • Baker CJ, Rench MA, McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine 2003; 21(24):3468-72; PMID:12850362; http://dx.doi.org/10.1016/S0264-410X(03)00353-0